AIM ImmunoTech Files 8-K
Ticker: AIM · Form: 8-K · Filed: Feb 5, 2025 · CIK: 946644
Sentiment: neutral
Topics: 8-k, filing, sec
TL;DR
AIM ImmunoTech filed an 8-K on Feb 5, 2025. Details TBD.
AI Summary
AIM ImmunoTech Inc. filed an 8-K report on February 5, 2025, to disclose other events and financial statements. The filing does not contain specific financial figures or details about the 'other events' in the provided text.
Why It Matters
This filing indicates AIM ImmunoTech is providing updates to the SEC, which could relate to ongoing operations or new developments.
Risk Assessment
Risk Level: low — The filing is a standard procedural disclosure without immediate financial or operational news.
Key Players & Entities
- AIM ImmunoTech Inc. (company) — Registrant
- February 5, 2025 (date) — Date of Report
- Delaware (jurisdiction) — State of Incorporation
- 001-27072 (identifier) — SEC File Number
- 52-0845822 (identifier) — IRS Employer Identification No.
- 2117 SW Highway 484, Ocala FL 34473 (address) — Principal executive offices
- (352) 448-7797 (phone_number) — Registrant's telephone number
FAQ
What specific 'Other Events' are being reported by AIM ImmunoTech Inc. in this 8-K filing?
The provided text of the 8-K filing does not specify the details of the 'Other Events'.
When was this 8-K report filed with the SEC?
This 8-K report was filed on February 5, 2025.
What is the principal executive office address for AIM ImmunoTech Inc.?
The principal executive office address is 2117 SW Highway 484, Ocala FL 34473.
What is the SEC File Number for AIM ImmunoTech Inc.?
The SEC File Number for AIM ImmunoTech Inc. is 001-27072.
What is the IRS Employer Identification Number for AIM ImmunoTech Inc.?
The IRS Employer Identification Number for AIM ImmunoTech Inc. is 52-0845822.
Filing Stats: 624 words · 2 min read · ~2 pages · Grade level 12 · Accepted 2025-02-05 08:30:24
Key Financial Figures
- $0.001 — ch registered Common Stock, par value $0.001 per share AIM NYSE American Item
Filing Documents
- form8-k.htm (8-K) — 40KB
- ex99-1.htm (EX-99.1) — 14KB
- ex99-1_001.jpg (GRAPHIC) — 56KB
- 0001493152-25-004948.txt ( ) — 305KB
- aim-20250205.xsd (EX-101.SCH) — 3KB
- aim-20250205_lab.xml (EX-101.LAB) — 33KB
- aim-20250205_pre.xml (EX-101.PRE) — 24KB
- form8-k_htm.xml (XML) — 3KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. AIM ImmunoTech Inc. Date: February 5, 2025 By /s/ Thomas K. Equels Thomas K. Equels, CEO -3-